Facebook
X
LinkedIn
ForwardSubstance Use Disorders Management Boot Camp - ASAM Region VI Conference (September 24, 2025)
Overview
This training aims to enhance confidence and competencies related to the management of substance use disorders in general medical settings. Through case-based and interactive didactic content, the workshop will explore issues related to assessment, monitoring, prevention, and management in the setting of unhealthy substance use.
Intended Audience
This program is designed for physicians, physician assistants, advanced practice nurses, nurses, pharmacists, social workers, students, residents, and fellows who treat patients with opioid use disorder.
Learning Objectives
As a result of participating in this activity, learners, as members of the healthcare team, will be able to:
- Determine accurate diagnosis and initiate treatment for opioid use disorder, alcohol withdrawal, and alcohol use disorder
- Demonstrate medical management and brief counseling skills needed to to work with patients who continue to use drugs and alcohol while in treatment for use disorder
- Determine appropriate treatment plan for OUD and AUD, including the initiation and maintenance of buprenorphine therapy, alcohol withdrawal management, and MAUD.
- Develop approaches to working with and managing patients with stimulant use disorders and/or Hepatitis C.
Elements of Competence
This educational activity is designed to change learner competence and focuses on the following competencies:
- Accreditation Council for Graduate Medical Education (ACGME)/Nursing: Patient care and procedural skills, medical knowledge, interpersonal and communication skills, and professionalism.
- National Academy of Medicine (NAM)/Nursing: Provide patient/person-centered care, employ evidence-based practice, population health
- Interprofessional Education Collaborative Competencies: Values/ethics for interprofessional practice, roles and responsibilities, communication, and teams and teamwork
- UW ICEP Diversity, Equity, and Inclusion: Engage in self-reflection and value diversity in the clinical encounter
Practice Gaps and Needs
Opioid use disorder can be challenging to treat in the primary care or office setting. The standards, methods and best practices in prescribing Medications for Opioid Use Disorder (MOUD), in particular Buprenorphine, change regularly and healthcare teams require up to date information on these practices. Providers lack a clear understanding in how to offer MOUD, and fail to comprehend how to interpret urine toxicology screens. Additionally, providers expressed interest in more education related to the logistical challenges commonly encountered when treating patients with complex opioid use disorders.
Agenda
| 10:00 AM | Welcome and Introductions |
| 10:15 AM | Opioid Use Disorder 101: Chronic Disease Management in the Age of Fentanyl |
| Kelly Eagen, MD, Assistant Professor, Department of Family Medicine and Community Health, Associate Program Director, Addiction Medicine Fellowship, UW-Madison School of Medicine and Public Health | |
| 11:15 AM | Common Challenges case discussion |
| 12:00 PM | Break |
| 12:10 PM | Chronic Pain, Opioids and Opioid Misuse |
| Randy Brown, MD, PhD, DFASAM, PROTEA Director, Professor in the Department of Family Medicine and Community Health, Director of the UW Center for Addictive Disorders, Program Director, UW Addiction Medicine Fellowship Programs | |
| 1:15 PM | Lunch |
| 1:45 PM | Alcohol Use Disorder / case discussion |
| Randy Brown, MD, PhD, DFASAM, PROTEA Director, Professor in the Department of Family Medicine and Community Health, Director of the UW Center for Addictive Disorders, Program Director, UW Addiction Medicine Fellowship Programs | |
| 3:00 PM | Stimulant Use Disorder / case discussion |
| David Leinweber, MD, MS, Assistant Professor, Department of Family Medicine and Community Health | |
| 3:45 PM | Long- acting Buprenorphine Products |
| David Leinweber, MD, MS, Assistant Professor, Department of Family Medicine and Community Health | |
| 4:15 PM | Wrap up / Harm reduction / Resources |
| 4:30 PM | Adjourn |
Additional venue booking information: https://www.hyatt.com/en-US/group-booking/MKERM/G-WSAM
For additional questions, please contact Kathleen Maher, [email protected].
Learners are responsible for their own transportation and lodging.
Planning Committee
| Randy Brown MD, PhD, DFASAM, Professor, UW School of Medicine & Public Health |
| Kelly Eagen, MD, Assistant Professor, Department of Family Medicine and Community Health, Associate Program Director, Addiction Medicine Fellowship, UW-Madison School of Medicine and Public Health |
| James Eberhard, MFA, Accreditation Specialist, Office of Continuing Professional Development, UW-Madison School of Medicine and Public Health |
| David Leinweber, MD, MS, Assistant Professor, Department of Family Medicine and Community Health |
| Jill Lindwall, MSN, RN, CPHQ, Clinical Staff Educator at University of Wisconsin Medical Foundation |
| Kathleen Maher, Outreach Specialist, Department of Family Medicine and Community Health |
| Robert Redwood, MD, MPH, Emergency Physician at Absaroka Emergency Physicians, Bozeman, MT |
| Maggie Williams, MPAS, PA-C, CPAAPA, Addiction Medicine Physician Assistant, UW Health |
Faculty
| Randy Brown MD, PhD, DFASAM, Professor, UW School of Medicine & Public Health |
| Kelly Eagen, MD, Assistant Professor, Department of Family Medicine and Community Health, Associate Program Director, Addiction Medicine Fellowship, UW-Madison School of Medicine and Public Health |
| David Leinweber, MD, MS, Assistant Professor, Department of Family Medicine and Community Health |
| Robert Redwood, MD, MPH, Emergency Physician at Absaroka Emergency Physicians, Bozeman, MT |
| Maggie Williams, MPAS, PA-C, CPAAPA, Addiction Medicine Physician Assistant, UW Health |
Policy on Disclosure
It is the policy of the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) to identify, mitigate and disclose all relevant financial relationships with ineligible companies* held by the speakers/presenters, authors, planners, and other persons who may influence the content of this accredited continuing education (CE). In addition, speakers, presenters and authors must disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation.
*Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. The ACCME does not consider providers of clinical services directly to patients to be ineligible companies.
For this accredited continuing education activity all relevant financial relationships have been mitigated and detailed disclosures are listed below:
| Name | Role | Relevant Financial Relationships Disclosed | Discussion of Unlabeled/Unapproved Uses of Drugs/Devices in Presentation? |
| Randy Brown MD, PhD, DFASAM | Clinical Director/Planning Committee Chair, Faculty | No relevant relationships with ineligible companies to disclose | No |
| Kelly Eagen, MD | Planning Committee Member, Faculty | No relevant relationships with ineligible companies to disclose | No |
| James Eberhard, MFA | Accreditation Specialist | No relevant relationships with ineligible companies to disclose | No |
| David Leinweber, MD, MS | Planning Committee Member, Faculty | No relevant relationships with ineligible companies to disclose | No |
| Jill Lindwall, MSN, RN, CPHQ | Planning Committee Member | No relevant relationships with ineligible companies to disclose | No |
| Kathleen Maher | Activity Coordinator | No relevant relationships with ineligible companies to disclose | No |
| Robert Redwood, MD, MPH | Planning Committee Member, Faculty | No relevant relationships with ineligible companies to disclose | No |
| Maggie Williams, MPAS, PA-C, CPAAPA | Planning Committee Member, Faculty | No relevant relationships with ineligible companies to disclose | No |
| Accreditation Logos | Accreditation Statements |
 | In support of improving patient care, the University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. |
Credit Designation Statements
American Medical Association (AMA) The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 5.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. | |
American Nurses Credentialing Center (ANCC) The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 5.25 ANCC contact hours, 3.5 of which are eligible for pharmacotherapeutic contact hours. | |
 | American Academy of Physician Assistants (AAPA) The University of Wisconsin–Madison ICEP has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 5.25 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation. |
Wisconsin Medical Examining Board Opioid CME This course is approved by the Wisconsin Medical Examining Board as meeting the requirements for a continuing education course on the responsible opioid prescribing guidelines per Med 13.03(3) of the Wisconsin Administrative Code. Course Title: Substance Use Disorders Management Boot Camp - ASAM Region VI Conference (September 24, 2025) | |
Medication Access and Training Expansion (MATE) Act This course is designed to meet the requirements outlined in the Medication Access and Training Expansion (MATE) Act. (Click here for more information.) | |
Continuing Education Units (CEUs) The University of Wisconsin–Madison ICEP, as a member of the University Professional & Continuing Education Association (UPCEA), authorizes this program for 0.525 CEUs or 5.25 hours. |
Available Credit
- 5.25 AAPA Category 1 CME
- 5.25 Wisconsin Responsible Opioid Prescribing Credit
- 5.25 AMA PRA Category 1 Credit™
- 5.25 Wisconsin Responsible Opioid Prescribing Credit
- 5.25 ANCC Contact Hours
- 5.25 Wisconsin Responsible Opioid Prescribing Credit
- 5.25 University of Wisconsin–Madison Continuing Education Hours
- 5.25 Approved for AMA PRA Category 1 Credit™
- 5.25 Wisconsin Responsible Opioid Prescribing Credit
To register for this event, please visit: https://www.wisam-asam.org/page-1075427
This activity is in-person only.
Registration for this activity can only be completed through the ICEP Learning Portal. Attendee registrations made through any other sites cannot be honored. UW-Madison ICEP is not able to refund fees paid through unaffiliated registration sites, such as eMedEvents.com, MedConfWorld.com, EventEgg.com, and 10times.com. Please report any unauthorized websites or solicitations for registrations to [email protected].
Questions about event, venue, or registration
Email Kathleen Maher [email protected]
Questions about claiming CE credit or help with ICEP Learning Portal
Email [email protected].
Program changes
Emergency situations occasionally occur and may necessitate topic or speaker changes. The University of Wisconsin School of Medicine and Public Health and the University of Wisconsin–Madison ICEP reserve the right to alter or substitute a topic or speaker without prior notification.
Accessibility
We value inclusion and access for all participants and are pleased to provide reasonable accommodation for this event. Please contact [email protected] as soon as you can make a reasonable accommodation request.
For further information
For additional questions about the conference, including accessibility requests, please contact: Kathleen Maher [email protected].